Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-27

Clinical Trial Update: Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a single injection of SCH 900962 to daily recFSH for controlled ovarian stimulation in infertility showed results post-completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCH 900962

Snippet

Sponsor: Organon and Co | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2012-12-27